Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 50 out of 59Page size: 50
  1. 2023
  2. Published

    A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    Dicanio, M., Giaccherini, M., Clay-Gilmour, A., Macauda, A., Sainz, J., Machiela, M. J., Rybicka-Ramos, M., Norman, A. D., Tyczyńska, A., Chanock, S. J., Barington, T., Kumar, S. K., Bhatti, P., Cozen, W., Brown, E. E., Suska, A., Haastrup, E. K., Orlowski, R. Z., Dudziński, M., Garcia-Sanz, R. & 42 others, Kruszewski, M., Martinez-Lopez, J., Beider, K., Iskierka-Jazdzewska, E., Pelosini, M., Berndt, S. I., Raźny, M., Jamroziak, K., Rajkumar, S. V., Jurczyszyn, A., Vangsted, Annette Juul, Collado, P. G., Vogel, U., Hofmann, J. N., Petrini, M., Butrym, A., Slager, S. L., Ziv, E., Subocz, E., Giles, G. G., Andersen, N. F., Mazur, G., Watek, M., Lesueur, F., Hildebrandt, M. A. T., Zawirska, D., Ebbesen, L. H., Marques, H., Gemignani, F., Dumontet, C., Várkonyi, J., Buda, G., Nagler, A., Druzd-Sitek, A., Wu, X., Kadar, K., Camp, N. J., Grzasko, N., Waller, R. G., Vachon, C., Canzian, F. & Campa, D., 2023, In: International Journal of Cancer. 152, 2, p. 239-248 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation

    Bertelsen, L. D., Børty Nielsen, L., Christensen, H. S., Bøgsted, M., Gregersen, H., Pedersen, R. S., Klostergaard, A., Schnack, B. I., Pedersen, P. T., Abildgaard, N., Hermansen, E., Vangsted, Annette Juul & Severinsen, M. T., 2023, In: European Journal of Haematology. 110, 3, p. 289-295 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Improved survival in myeloma patients– a nationwide registry study of 4647 patients ≥75 years treated in Denmark and Sweden

    Moore, K. L. F., Turesson, I., Genell, A., Klausen, T. W., Knut-bojanowska, D., Redder, L., Sverrisdottir, I., Thorsen, J., Vangsted, Annette Juul, Blimark, C. H. & Nordic Myeloma Study Group, N. M. S. G., 2023, In: Haematologica. 108, 6, p. 1640-1651 43 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Lenalidomide Maintenance in Multiple Myeloma: A Retrospective, Nationwide, Real-World Study

    Harsløf, Mads, Chanchiri, I., Silkjær, T., Frølund, U. C., Teodorescu, E. M., Nielsen, K. B., Nielsen, P. I., Pedersen, P. T., Iversen, K. F., Grønbæk, Kirsten, Vangsted, Annette Juul, Thorsteinsdottir, S. & Szabo, A. G., 2023, In: Blood. 142, Supplement 1, p. 1979 1 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

    Terpos, E., Musto, P., Engelhardt, M., Delforge, M., Cook, G., Gay, F., van de Donk, N. W. C. J., Ntanasis-Stathopoulos, I., Vangsted, A. J., Driessen, C., Schjesvold, F., Cerchione, C., Zweegman, S., Hajek, R., Moreau, P., Einsele, H., San-Miguel, J., Boccadoro, M., Dimopoulos, M. A., Sonneveld, P. & 1 others, Ludwig, H., 2023, In: Leukemia. 37, 6, p. 1175-1185 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma

    Plesner, T., Harrison, S. J., Quach, H., Lee, C., Bryant, A., Vangsted, Annette Juul, Estell, J., Delforge, M., Offner, F., Twomey, P., Choeurng, V., Li, J., Hendricks, R., Ruppert, S. M., Sumiyoshi, T., Miller, K., Cho, E. & Schjesvold, F., 2023, In: Clinical Hematology International. 5, 1, p. 43-51 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

    Clavero, E., Sanchez-Maldonado, J. M., Macauda, A., Ter Horst, R., Sampaio-Marques, B., Jurczyszyn, A., Clay-Gilmour, A., Stein, A., Hildebrandt, M. A. T., Weinhold, N., Buda, G., García-Sanz, R., Tomczak, W., Vogel, U., Jerez, A., Zawirska, D., Wątek, M., Hofmann, J. N., Landi, S., Spinelli, J. J. & 52 others, Butrym, A., Kumar, A., Martínez-López, J., Galimberti, S., Sarasquete, M. E., Subocz, E., Iskierka-Jażdżewska, E., Giles, G. G., Rybicka-Ramos, M., Kruszewski, M., Abildgaard, N., Verdejo, F. G., Sánchez Rovira, P., da Silva Filho, M. I., Kadar, K., Razny, M., Cozen, W., Pelosini, M., Jurado, M., Bhatti, P., Dudzinski, M., Druzd-Sitek, A., Orciuolo, E., Li, Y., Norman, A. D., Zaucha, J. M., Reis, R. M., Markiewicz, M., Rodríguez Sevilla, J. J., Andersen, V., Jamroziak, K., Hemminki, K., Berndt, S. I., Rajkumar, V., Mazur, G., Kumar, S. K., Ludovico, P., Nagler, A., Chanock, S. J., Dumontet, C., Machiela, M. J., Varkonyi, J., Camp, N. J., Ziv, E., Vangsted, Annette Juul, Brown, E. E., Campa, D., Vachon, C. M., Netea, M. G., Canzian, F., Försti, A. & Sainz, J., 2023, In: International Journal of Molecular Sciences. 24, 10, 20 p., 8500.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Potential value of pre-planned imaging of bone disease in multiple myeloma

    Nordic Myeloma Study Group, N. M. S. G., 2023, In: Blood Cancer Journal. 13, 1, 5 p., 105.

    Research output: Contribution to journal › Editorial › Research › peer-review

  10. 2022
  11. Published

    A polygenic risk score for multiple myeloma risk prediction

    Canzian, F., Piredda, C., Macauda, A., Zawirska, D., Andersen, N. F., Nagler, A., Zaucha, J. M., Mazur, G., Dumontet, C., Wątek, M., Jamroziak, K., Sainz, J., Várkonyi, J., Butrym, A., Beider, K., Abildgaard, N., Lesueur, F., Dudziński, M., Vangsted, A. J., Pelosini, M. & 20 others, Subocz, E., Petrini, M., Buda, G., Raźny, M., Gemignani, F., Marques, H., Orciuolo, E., Kadar, K., Jurczyszyn, A., Druzd-Sitek, A., Vogel, U., Andersen, V., Reis, R. M., Suska, A., Avet-Loiseau, H., Kruszewski, M., Tomczak, W., Rymko, M., Minvielle, S. & Campa, D., 2022, In: European Journal of Human Genetics. 30, 4, p. 474-479 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

    Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U. C., Axelsson, P., Stromberg, O., Blimark, C. H., Crafoord, J., Tsykunova, G., Eshoj, H. R., Waage, A., Hansson, M. & 1 others, Gulbrandsen, N., 2022, In: European Journal of Haematology. 108, 1, p. 34-44 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

    MacAuda, A., Clay-Gilmour, A., Hielscher, T., Hildebrandt, M. A. T., Kruszewski, M., Orlowski, R. Z., Kumar, S. K., Ziv, E., Orciuolo, E., Brown, E. E., Försti, A., Waller, R. G., MacHiela, M. J., Chanock, S. J., Camp, N. J., Rymko, M., Raźny, M., Cozen, W., Várkonyi, J., Piredda, C. & 36 others, Pelosini, M., Belachew, A. A., Subocz, E., Hemminki, K., Rybicka-Ramos, M., Giles, G. G., Milne, R. L., Hofmann, J. N., Zaucha, J. M. I., Vangsted, Annette Juul, Goldschmidt, H., Rajkumar, S. V., Tomczak, W., Sainz, J., Butrym, A., Watek, M., Iskierka-Jazdzewska, E., Buda, G., Robinson, D. P., Jurczyszyn, A., Dudzinski, M., Martinez-Lopez, J., Sinnwell, J. P., Slager, S. L., Jamroziak, K., Reis, R. M. V., Weinhold, N., Bhatti, P., Carvajal-Carmona, L. G., Zawirska, D., Norman, A. D., Mazur, G., Berndt, S. I., Campa, D., Vachon, C. M. & Canzian, F., 2022, In: Cancer Epidemiology Biomarkers and Prevention. 31, 9, p. 1863-1866

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries

    Blimark, C. H., Vangsted, Annette Juul, Klausen, T. W., Gregersen, H., Szabo, A. G., Hermansen, E., Wålinder, G., Knut-Bojanowska, D., Zang, C., Turesson, I. & the Real-World Evidence Group within the Nordic Myeloma Study Group (NMSG), T. R. E. G. W. T. N. M. S. G. (., 2022, In: European Journal of Haematology. 108, 2, p. 99-108 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy

    Szabo, A. G., Thorsen, J., Iversen, K. F., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C. N., Andersen, M. K. & Vangsted, Annette Juul, 2022, In: American Journal of Hematology. 97, 3, p. E117-E120

    Research output: Contribution to journal › Letter › Research › peer-review

  16. Published

    The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease

    Richardson, P. G., Mateos, M. V., Vangsted, Annette Juul, Ramasamy, K., Abildgaard, N., Ho, P. J., Quach, H. & Bahlis, N. J., 2022, In: Expert Review of Proteomics. 19, 4-6, p. 235-246

    Research output: Contribution to journal › Review › Research › peer-review

  17. 2021
  18. Published

    Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival

    Melaiu, O., Macauda, A., Sainz, J., Calvetti, D., Facioni, M. S., Maccari, G., ter Horst, R., Netea, M. G., Li, Y., Grząśko, N., Moreno, V., Jurczyszyn, A., Jerez, A., Watek, M., Varkonyi, J., Garcia-Sanz, R., Kruszewski, M., Dudziński, M., Kadar, K., Jacobsen, S. E. H. & 34 others, Mazur, G., Andersen, V., Rybicka, M., Zawirska, D., Raźny, M., Zaucha, J. M., Ostrovsky, O., Iskierka-Jazdzewska, E., Reis, R. M., Stępień, A., Beider, K., Nagler, A., Druzd-Sitek, A., Marques, H., Martìnez-Lopez, J., Lesueur, F., Avet-Loiseau, H., Vangsted, Annette Juul, Krawczyk-Kulis, M., Butrym, A., Jamroziak, K., Dumontet, C., Vogel, U., Rymko, M., Pelosini, M., Subocz, E., Szombath, G., Sarasquete, M. E., Silvestri, R., Morani, F., Landi, S., Campa, D., Canzian, F. & Gemignani, F., 15 Apr 2021, In: International Journal of Cancer. 148, 8, p. 1887-1894 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde

    Musto, P., Engelhardt, M., Caers, J., Bolli, N., Kaiser, M., van de Donk, N., Terpos, E., Broijl, A., de Larrea, C. F., Gay, F., Goldschmidt, H., Hajek, R., Vangsted, A. J., Zamagni, E., Zweegman, S., Cavo, M., Dimopoulos, M., Einsele, H., Ludwig, H., Barosi, G. & 4 others, Boccadoro, M., Mateos, M. V., Sonneveld, P. & Miguel, J. S., 2021, In: Haematologica. 106, 11, p. 2799-2812

    Research output: Contribution to journal › Review › Research › peer-review

  20. Published

    Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio

    Szabo, A. G., Klausen, T. W., Abildgaard, N., Gregersen, H., Silkjær, T., Pedersen, P. T., Pedersen, R. S., Helleberg, C., Hermansen, E., Schnack, B. I. & Vangsted, Annette Juul, 2021, In: Blood Cancer Journal. 11, 4, 70.

    Research output: Contribution to journal › Letter › Research › peer-review

  21. Published

    Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients

    Højholt, K. L., Gregersen, H., Szabo, A. G., Klausen, T. W., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Iversen, K. F., Teodorescu, E. M., Kurt, E., Strandholdt, C., Andersen, M. K. & Vangsted, Annette Juul, 2021, In: Hematological Oncology. 39, 4, p. 521-528

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14)

    Bahlis, N. J., Baz, R., Harrison, S. J., Quach, H., Ho, S. J., Vangsted, Annette Juul, Plesner, T., Moreau, P., Gibbs, S. D., Coppola, S., Yang, X., Al Masud, A., Ross, J. A., Bueno, O. & Kaufman, J. L., 2021, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39, 32, p. 3602-3612

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    The real-world outcomes of multiple myeloma patients treated with daratumumab

    Szabo, A. G., Klausen, T. W., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Iversen, K. F., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C., Andersen, M. K. & Vangsted, Annette Juul, 2021, In: Plos One. 16, 10 October, p. 1-11 e0258487.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry

    Redder, L., Klausen, T. W., Vangsted, Annette Juul, Gregersen, H., Andersen, N. F., Pedersen, R. S., Szabo, A. G., Frederiksen, M., Frølund, U. C., Helleberg, C., Nielsen, L. K., Pedersen, P. T., Salomo, M., Gimsing, P., Frederiksen, H. & Abildgaard, N., 2021, In: British Journal of Haematology. 193, 1, p. 119-124 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. 2020
  26. Published

    Clinically-suspected cast nephropathy: A retrospective, national, real-world study

    Szabo, A. G., Thorsen, Jonathan Jan Ilve, Iversen, K. F., Hansen, C. T., Teodorescu, E. M., Pedersen, S. B., Flaeng, S. B., Strandholdt, C., Frederiksen, M., Vase, M. Ø., Frølund, U. C., Krustrup, D., Plesner, T. & Vangsted, Annette Juul, 2020, In: American Journal of Hematology. 95, 11, p. 1352-1360 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts

    Agrawal, A., Kruse, L. S., Vangsted, Annette Juul, Gartland, A. & Jørgensen, Niklas Rye, 2020, In: Cells. 9, 11

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

    Terpos, E., Engelhardt, M., Cook, G., Gay, F., Mateos, M. V., Ntanasis-Stathopoulos, I., van de Donk, N. W. C. J., Avet-Loiseau, H., Hajek, R., Vangsted, Annette Juul, Ludwig, H., Zweegman, S., Moreau, P., Einsele, H., Boccadoro, M., San Miguel, J., Dimopoulos, M. A. & Sonneveld, P., 2020, In: Leukemia. 34, 8, p. 2000-2011 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  29. 2019
  30. Published

    Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

    Campa, D., Martino, A., Macauda, A., Dudziński, M., Suska, A., Druzd-Sitek, A., Raab, M-S., Moreno, V., Huhn, S., Butrym, A., Sainz, J., Szombath, G., Rymko, M., Marques, H., Lesueur, F., Vangsted, A. J., Vogel, U., Kruszewski, M., Subocz, E., Buda, G. & 27 others, Iskierka-Jażdżewska, E., Ríos, R., Merz, M., Schöttker, B., Mazur, G., Perrial, E., Martinez-Lopez, J., Butterbach, K., García Sanz, R., Goldschmidt, H., Brenner, H., Jamroziak, K., Reis, R. M., Kadar, K., Dumontet, C., Wątek, M., Haastrup, E. K., Helbig, G., Jurczyszyn, A., Jerez, A., Varkonyi, J., Barington, T., Grzasko, N., Zaucha, J. M., Andersen, V., Zawirska, D. & Canzian, F., Jul 2019, In: Leukemia and Lymphoma. 60, 7, p. 1803-1811 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  31. Published

    The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

    Klausen, T. W., Gregersen, H., Abildgaard, N., Andersen, N. F., Frølund, U. C., Gimsing, P., Helleberg, C. & Vangsted, Annette Juul, Feb 2019, In: Leukemia. 33, 2, p. 546-549 4 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  32. Published

    Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

    PRACTICAL consortium, P. C., 10 Jan 2019, In: Nature Communications. 10, 1, 3 p., 213.

    Research output: Contribution to journal › Journal article › Research › peer-review

  33. Published

    Clarithromycin added to bortezomib-cyclophosphamide-dexamethasone impairs health-related quality of life in multiple myeloma patients

    Nielsen, L. K., Klausen, T. W., Jarden, Mary Ellen, Frederiksen, H., Vangsted, Annette Juul, Do, T., Kristensen, I. B., Frølund, U. C., Andersen, Christen Bertel L, Abildgaard, N. & Gregersen, H., Jan 2019, In: European Journal of Haematology. 102, 1, p. 70-78 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  34. Published

    Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, Annette Juul & Gimsing, P., 2019, In: European Journal of Haematology. 102, 2, p. 182-190

    Research output: Contribution to journal › Journal article › Research › peer-review

  35. 2018
  36. Published

    Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

    Went, M., Sud, A., Försti, A., Halvarsson, B. M., Weinhold, N., Kimber, S., van Duin, M., Thorleifsson, G., Holroyd, A., Johnson, D. C., Li, N., Orlando, G., Law, P. J., Ali, M., Chen, B., Mitchell, J. S., Gudbjartsson, D. F., Kuiper, R., Stephens, O. W., Bertsch, U. & 31 others, Broderick, P., Campo, C., Bandapalli, O. R., Einsele, H., Gregory, W. A., Gullberg, U., Hillengass, J., Hoffmann, P., Jackson, G. H., Jöckel, K. H., Johnsson, E., Kristinsson, S. Y., Mellqvist, U. H., Nahi, H., Easton, D., Pharoah, P., Dunning, A., Peto, J., Canzian, F., Swerdlow, A., Eeles, R. A., Kote-Jarai, Z. S., Muir, K., Pashayan, N., Nickel, J., Nöthen, M. M., Vangsted, Annette Juul, Andersen, N. F., Nilsson, B., Nordestgaard, Børge & The Practical Consortium, T. P. C., 13 Sep 2018, In: Nature Communications. 9, 10 p., 3707.

    Research output: Contribution to journal › Journal article › Research › peer-review

  37. Published

    A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

    Gregersen, H., Do, T., Kristensen, I. B., Frølund, U. C., Andersen, N. F., Nielsen, L. K., Andersen, Christen Bertel L, Klausen, T. W., Vangsted, Annette Juul & Abildgaard, N., 2018, In: Experimental Hematology & Oncology. 7, 1, 18.

    Research output: Contribution to journal › Journal article › Research › peer-review

  38. Published

    Drug response prediction in high-risk multiple myeloma

    Vangsted, Annette Juul, Helm-Petersen, S., Cowland, J. B., Jensen, P. B., Gimsing, P., Barlogie, B. & Knudsen, S., 2018, In: Gene. 644, p. 80-86 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  39. Published

    Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014

    Helm-Petersen, S., Sørrig, R., Klausen, T. W., Preiss, B., Frølund, U. C., Helleberg, C., Breinholt, M., Andersen, M. K., Abildgaard, N., Gimsing, P. & Vangsted, Annette Juul, 2018, In: Leukemia. 32, p. 2054-2057

    Research output: Contribution to journal › Journal article › Research › peer-review

  40. Published

    Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

    Macauda, A., Castelli, E., Buda, G., Pelosini, M., Butrym, A., Watek, M., Kruszewski, M., Vangsted, A. J., Rymko, M., Jamroziak, K., Abildgaard, N., Haastrup, E. K., Mazur, G., Ríos, R., Jurczyszyn, A., Zawirska, D., Dudziński, M., Raźny, M., Dutka, M., Tomczak, W. & 11 others, Suska, A., Druzd-Sitek, A., Marques, H., Petrini, M., Markiewicz, M., Martinez-Lopez, J., Ebbesen, L. H., Iskierka-Jażdżewska, E., Sainz, J., Canzian, F. & Campa, D., 2018, In: British Journal of Haematology. 183, 3, p. 375-384 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  41. Published

    Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma

    Lund, J., Gruber, A., Lauri, B., Duru, A. D., Blimark, C., Swedin, A., Hansson, M., Forsberg, K., Ahlberg, L., Carlsson, C., Waage, A., Gimsing, P., Vangsted, Annette Juul, Frølund, U., Holmberg, E., Gahrton, G., Alici, E., Hardling, M., Mellqvist, U. & Nahi, H., 2018, In: Cancer Medicine. 7, 6, p. 2256-2268 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  42. Published

    Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in Denmark

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, Annette Juul & Gimsing, P., 2018, In: European Journal of Haematology. 101, 1, p. 21-27 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  43. 2017
  44. Published

    Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, Annette Juul, Frølund, U. C., Andersen, K. T., Klostergaard, A., Helleberg, C., Pedersen, R. S., Pedersen, P. T., Helm-Petersen, S., Teodorescu, E. M., Preiss, B., Abildgaard, N. & Gimsing, P., Dec 2017, In: PLoS ONE. 12, 12, 15 p., e0188988.

    Research output: Contribution to journal › Journal article › Research › peer-review

  45. Published

    The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study

    Gregersen, H., Vangsted, Annette Juul, Abildgaard, N., Andersen, N. F., Pedersen, R. S., Frølund, U. C., Helleberg, C., Broch, B., Pedersen, P. T., Gimsing, P. & Klausen, T. W., Jun 2017, In: Cancer Medicine. 6, 7, p. 1807-1816 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  46. Published

    Identification of miRSNPs associated with the risk of multiple myeloma

    Macauda, A., Calvetti, D., Maccari, G., Hemminki, K., Försti, A., Goldschmidt, H., Weinhold, N., Houlston, R., Andersen, V., Vogel, U., Buda, G., Varkonyi, J., Sureda, A., Martinez Lopez, J., Watek, M., Butrym, A., Sarasquete, M. E., Dudziński, M., Jurczyszyn, A., Druzd-Sitek, A. & 36 others, Kruszewski, M., Subocz, E., Petrini, M., Iskierka-Jażdżewska, E., Raźny, M., Szombath, G., Marques, H., Zawirska, D., Chraniuk, D., Halka, J., Hove Jacobsen, S. E., Mazur, G., García Sanz, R., Dumontet, C., Moreno, V., Stępień, A., Beider, K., Pelosini, M., Manuel Reis, R., Krawczyk-Kulis, M., Rymko, M., Avet-Loiseau, H., Lesueur, F., Grząśko, N., Ostrovsky, O., Jamroziak, K., Vangsted, Annette Juul, Jerez, A., Tomczak, W., Zaucha, J. M., Kadar, K., Sainz, J., Nagler, A., Landi, S., Gemignani, F. & Canzian, F., 1 Feb 2017, In: International Journal of Cancer. 140, 3, p. 526-534 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  47. Published

    Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry

    Thidemann Andersen, K., Klausen, T., Abildgaard, N., Klarskov Andersen, M., Frost Andersen, N., Christian Frølund, U., Helleberg, C., Kjeldsen, E., Pedersen, P., Helm-Petersen, S., Svirskaite, A., Preiss, B., Gimsing, P. & Vangsted, Annette Juul, 2017, In: American Journal of Hematology. 92, 10, p. E611-E614

    Research output: Contribution to journal › Comment/debate › Research

  48. Published

    Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival

    Nielsen, K. R., Rodrigo-Domingo, M., Steffensen, R., Baech, J., Bergkvist, K. S., Oosterhof, L., Schmitz, A., Bødker, J. S., Johansen, P., Vogel, U., Vangsted, Annette Juul, Dybkær, K., Bøgsted, M. & Johnsen, H. E., 2017, In: Leukemia and Lymphoma. 58, 11, p. 2695-2704

    Research output: Contribution to journal › Journal article › Research › peer-review

  49. 2016
  50. Published

    The Danish National Multiple Myeloma Registry

    Gimsing, P., Holmström, M. O., Klausen, T. W., Andersen, N. F., Gregersen, H., Pedersen, R. S., Plesner, T., Pedersen, P. T., Frederiksen, M., Frølund, U. C., Helleberg, C., Vangsted, Annette Juul, Brown, Peter de Nully & Abildgaard, N., 25 Oct 2016, In: Clinical Epidemiology. 8, p. 583-587 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  51. A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3

    Erickson, S. W., Stephens, O. W., Chavan, S. S., Epstein, J., Barlogie, B., Heuck, C. J. & Vangsted, Annette Juul, Sep 2016, In: British Journal of Haematology. 174, 6, p. 991-993 3 p.

    Research output: Contribution to journal › Comment/debate › Research

  52. Published

    Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, Annette Juul, Østergaard, B., Gregersen, H., Frølund, U. C., Andersen, N. F., Helleberg, C., Andersen, K. T., Pedersen, R. S., Pedersen, P., Abildgaard, N., Gimsing, P. & Danish Myeloma Study Group, D. M. S. G., Sep 2016, In: European Journal of Haematology. 97, 3, p. 303-9 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  53. Published

    Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation

    Hermansen, N. E. U., Borup, R., Andersen, M. K., Vangsted, Annette Juul, Clausen, T. N., Kristensen, D. L., Nielsen, Finn Cilius & Gimsing, P., Jun 2016, In: International Journal of Laboratory Hematology. 38, 3, p. 298-307 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  54. Published

    A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis

    Ríos-Tamayo, R., Lupiañez, C. B., Campa, D., Hielscher, T., Weinhold, N., Martinez-Lopez, J., Jerez, A., Landi, S., Jamroziak, K., Dumontet, C., Wątek, M., Lesueur, F., Reis, R. M., Marques, H., Jurczyszyn, A., Vogel, U., Buda, G., García-Sanz, R., Orciuolo, E., Petrini, M. & 8 others, Vangsted, Annette Juul, Gemignani, F., Försti, A., Goldschmidt, H., Hemminki, K., Canzian, F., Jurado, M. & Sainz, J., 2016, In: OncoTarget. 7, 37, p. 59029-59048 20 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  55. Published

    Genome-wide association study identifies multiple susceptibility loci for multiple myeloma

    Mitchell, J. S., Li, N., Weinhold, N., Försti, A., Ali, M., van Duin, M., Thorleifsson, G., Johnson, D. C., Chen, B., Halvarsson, B-M., Gudbjartsson, D. F., Kuiper, R., Stephens, O. W., Bertsch, U., Broderick, P., Campo, C., Einsele, H., Gregory, W. A., Gullberg, U., Henrion, M. & 38 others, Hillengass, J., Hoffmann, P., Jackson, G. H., Johnsson, E., Jöud, M., Kristinsson, S. Y., Lenhoff, S., Lenive, O., Mellqvist, U., Migliorini, G., Nahi, H., Nelander, S., Nickel, J., Nöthen, M. M., Rafnar, T., Ross, F. M., da Silva Filho, M. I., Swaminathan, B., Thomsen, H., Turesson, I., Vangsted, Annette Juul, Vogel, U., Waage, A., Walker, B. A., Wihlborg, A., Broyl, A., Davies, F. E., Thorsteinsdottir, U., Langer, C., Hansson, M., Kaiser, M., Sonneveld, P., Stefansson, K., Morgan, G. J., Goldschmidt, H., Hemminki, K., Nilsson, B. & Houlston, R. S., 2016, In: Nature Communications. 7, 9 p., 12050.

    Research output: Contribution to journal › Journal article › Research › peer-review

  56. 2015
  57. Published

    Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database

    Holmström, M. O., Gimsing, P., Abildgaard, N., Andersen, N. F., Helleberg, C., Clausen, N. A. T., Klausen, T. W., Frederiksen, M., Kristensen, D. L., Larsen, H., Pedersen, P. T., Andersen, K. T., Pedersen, R. S., Jensen, B. A., Gregersen, H. & Vangsted, Annette Juul, Apr 2015, In: American Journal of Hematology. 90, 4, p. E73-E74

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  58. Published

    Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

    Campa, D., Martino, A., Varkonyi, J., Lesueur, F., Jamroziak, K., Landi, S., Jurczyszyn, A., Marques, H., Andersen, V., Jurado, M., Brenner, H., Petrini, M., Vogel, U., García-Sanz, R., Buda, G., Gemignani, F., Ríos, R., Vangsted, A. J., Dumontet, C., Martínez-López, J. & 16 others, Moreno, M. J., Stępień, A., Wątek, M., Moreno, V., Dieffenbach, A. K., Rossi, A. M., Butterbach, K., Jacobsen, S. E. H., Goldschmidt, H., Sainz, J., Hillengass, J., Orciuolo, E., Dudziński, M., Weinhold, N., Reis, R. M. & Canzian, F., 1 Mar 2015, In: International Journal of Cancer. 136, 5, p. E351-8

    Research output: Contribution to journal › Journal article › Research › peer-review

  59. GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis

    Coleman, E. A., Lee, J. Y., Erickson, S. W., Goodwin, J. A., Sanathkumar, N., Raj, V. R., Zhou, D., McKelvey, K. D., Apewokin, S., Stephens, O., Enderlin, C. A., Vangsted, Annette Juul, Reed, P. J. & Anaissie, E. J., Mar 2015, In: Supportive Care in Cancer. 23, 3, p. 841-9 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 9762536